Non-contraceptive health benefits of intrauterine hormonal systems

Pharris, 1974, Progestasert®, a uterine therapeutic system for long-term contraception: philosophy and clinical efficacy, Fertil Steril, 25, 915, 10.1016/S0015-0282(16)40748-X Luukkainen, 1993, The levonorgestrel-releasing IUD, Br J Fam Plann, 19, 221 Mansour, 2007, Modern management of abnormal uterine bleeding - the levonorgestrel intrauterine system, Bailliere's Best Prac Res Clin Obstet Gynaecol, 21, 1007, 10.1016/j.bpobgyn.2007.03.023 Wildemeersch, 2004, Assessment of menstrual blood loss in women with idiopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system, Contraception, 70, 165, 10.1016/j.contraception.2004.02.005 Wildemeersch, 2005, Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system, Contraception, 71, 470, 10.1016/j.contraception.2004.12.004 Sivin, 1991, Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNG 20) and the copper T 380Ag IUDs, Contraception, 44, 473, 10.1016/0010-7824(91)90149-A Sivin, 1994, Health during prolonged use of levonorgestrel 20 mcg/day and the copper T Cu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research, Population Council, Fertil Steril, 61, 70, 10.1016/S0015-0282(16)56455-3 Mishell, 1982, jr. Non-contraceptive health benefits of oral steroidal contraceptives, Am J Obstet Gynecol, 142, 809, 10.1016/S0002-9378(16)32492-9 Ronnerdag, 1999, Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use, Acta Obstet Gynecol Scand, 78, 716, 10.1080/j.1600-0412.1999.780810.x National Institute for Health and Clinical Excellence, 2005 Volpe, 1982, An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia, Maturitas, 4, 73, 10.1016/0378-5122(82)90022-6 Bergqvist, 1983, Treatment of menorrhagia with intrauterine release of progesterone, Br J Obstet Gynaecol, 90, 255, 10.1111/j.1471-0528.1983.tb08620.x 1998, New Zealand Working Party for Guidelines for the Management of Heavy Menstrual Bleeding, NZ Med J, 112, 174 National Institute for Health and Clinical Excellence, 2007 Fraser, 2000, Defining disturbances of the menstrual cycle, 141 Woolcock, 2008, Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding, Fertil Steril, 90, 2269, 10.1016/j.fertnstert.2007.10.060 Fraser, 2007, Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?, Hum Reprod, 22, 635, 10.1093/humrep/del478 Fraser, 2007, A process designed to lead to international agreement on terminologies and definitions to describe abnormalities of menstrual bleeding, Fertil Steril, 87, 466, 10.1016/j.fertnstert.2007.01.023 Andersson, 1990, Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia, Br J Obstet Gynaecol, 97, 690, 10.1111/j.1471-0528.1990.tb16240.x Chrisman, 2007, The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and non-contraceptive uses, Clin Obstet Gynecol, 50, 886, 10.1097/GRF.0b013e318159c0d9 Marjoribanks, 2006, Surgery versus medical therapy for heavy menstrual bleeding, Cochrane Database Syst Rev, CD003855 Kaunitz, 2009, Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis, Obstet Gynecol, 113, 1104, 10.1097/AOG.0b013e3181a1d3ce Higham, 1990, Assessemnt of menstrual blood loss using a pictorial chart, Br J Obstet Gynaecol, 97, 734, 10.1111/j.1471-0528.1990.tb16249.x Hurskainen, 2001, Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial, Lancet, 357, 273, 10.1016/S0140-6736(00)03615-1 Reid, 2005, Trends in number of hysterectomies performed in England for menorrhagia. examination of health episode statistics, BMJ, 330, 938, 10.1136/bmj.38376.505382.AE Xiao, 2003, Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia, Fertil Steril, 79, 963, 10.1016/S0015-0282(02)04913-0 Kriplani, 2007, Efficacy, acceptability and side-effects of the levonorgestrel-releasing intrauterine system for menorrhagia, Int J Obstet Gynecol, 97, 190, 10.1016/j.ijgo.2007.01.009 Fraser, 2008, Menstrual confusion, Int J Gynecol Obstet, 100, 1, 10.1016/j.ijgo.2007.10.001 Hale GE, Manconi F, Fraser IS. Quantitative menstrual blood loss measurement in ovulatory and anovulatory cycles in mid to late reproductive age and the menopause transition. Obstet Gynecol [in press] Kadir, 2007, Levonorgestrel-releasing intrauterine system: bleeding disorders and anticoagulant therapy, Contraception, 75, S123, 10.1016/j.contraception.2007.01.005 Kingman, 2004, The use of the levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders, Br J Obstet Gynaecol, 111, 1425, 10.1111/j.1471-0528.2004.00305.x Schaedel, 2005, The use of levonorgestrel-releasing intrauterine system in the management of women with hemostatic disorders, Am J Obstet Gynecol, 193, 1361, 10.1016/j.ajog.2005.05.002 Lukes, 2008, Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders, Fertil Steril, 90, 673, 10.1016/j.fertnstert.2007.07.1315 Vilos, 2009, The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy, J Min Invas Gynecol, 16, 480, 10.1016/j.jmig.2009.04.018 Kaunitz, 2007, Progestin-releasing intrauterine systems and leiomyoma, Contraception, 75, S130, 10.1016/j.contraception.2007.01.012 Mercorio, 2003, The effect of a levonorgestrel-releasing intrauterine system in the treatment of myoma-related menorrhagia, Contraception, 67, 277, 10.1016/S0010-7824(02)00522-X Grigorieva, 2003, Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to intrauterine leiomyomas, Fertil Steril, 79, 1194, 10.1016/S0015-0282(03)00175-4 Soysal, 2005, The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia, Gynecol Obstet Invest, 5, 29, 10.1159/000080932 Magalhaes, 2007, Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas, Contraception, 75, 193, 10.1016/j.contraception.2006.11.004 Fedele, 1997, Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device, Fertil Steril, 68, 426, 10.1016/S0015-0282(97)00245-8 Bragheto, 2007, Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging, Contraception, 76, 195, 10.1016/j.contraception.2007.05.091 Cho, 2008, Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis, Am J Obstet Gynecol, 198, 373, 10.1016/j.ajog.2007.10.798 Fong, 1999, Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system, Contraception, 60, 173, 10.1016/S0010-7824(99)00075-X Imperato, 2002, The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status, Minerva Gynecol, 54, 271 Lilhong, 1999, Investigation on the prevalence and influencing factors to anaemia in women of reproductive age, China J Epidemiol, 20, 158 Varma, 2008, The effectiveness of a levonorgestrel-releasing intrauterine system in the treatment of endometrial hyperplasia - a long-term follow-up study, Eur J Obstet Gynecol Reprod Biol, 139, 169, 10.1016/j.ejogrb.2008.02.022 Orbo, 2008, Treatment results of endometrial hyperplasia after prospective D-score classification. A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only, Gynecol Oncol, 111, 68, 10.1016/j.ygyno.2008.06.014 Orbo, 2006, Regression of latent endometrial precancers by progestin infiltrated intrauterine device, Cancer Res, 66, 5613, 10.1158/0008-5472.CAN-05-4321 Bahamondes, 2003, Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma, Acta Obstet Gynecol Scand, 82, 580 Dhar-Kalyan, 2005, Is the levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature, Gynecol Oncol, 97, 924, 10.1016/j.ygyno.2004.10.031 Vercellini, 1999, A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study, Fertil Steril, 72, 505, 10.1016/S0015-0282(99)00291-5 Petta, 2005, Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis, Hum Reprod, 20, 1993, 10.1093/humrep/deh869 Bahamondes, 2007, Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea, Contraception, 75, S134, 10.1016/j.contraception.2006.12.008 Vercellini, 2003, Comparison of a levonorgestrel-releasing intrauterine system versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study, Fertil Steril, 80, 305, 10.1016/S0015-0282(03)00608-3 Fraser, 2007, The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease, Contraception, 75, S112, 10.1016/j.contraception.2006.12.013 Henderson, 1993, Hormonal chemoprevention of cancer in women, Science, 259, 633, 10.1126/science.8381558 Toivonen, 1991, Protective effects of intrauterine release of levonorgestrel on pelvic infection. Three years of comparative experience of levonorgestrel and copper-releasing intrauterine devices, Obstet Gynecol, 77, 261, 10.1097/00006250-199102000-00019 Bagwell, 1995, Primary infertility and oral contraceptive steroid use, Fertil Steril, 63, 1161, 10.1016/S0015-0282(16)57590-6 Nilsson, 1982, Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD, Clin Endocrinol, 17, 529, 10.1111/j.1365-2265.1982.tb01625.x Hurskainen, 2000, Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel, Mol Hum Reprod, 6, 1013, 10.1093/molehr/6.11.1013 Hidalgo, 2009, Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel releasing intrauterine system, Contraception, 80, 84, 10.1016/j.contraception.2009.01.004 Maruo, 2001, Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium, Hum Reprod, 16, 2103, 10.1093/humrep/16.10.2103 Short, 1976, The evolution of human reproduction, Proc Roy Soc Lond B, 195, 3, 10.1098/rspb.1976.0095 Eaton, 1994, Women's reproductive cancers in evolutionary context, Quart Rev Biol, 69, 353, 10.1086/418650